Preclinical researches have demonstrated that the combination of DSF and Cu (II) specifically targets and kills aldehyde dehydrogenase (ALDH)+ cancer stem cells, decreasing the risk of tumor recurrence [115, 116]. The gene discussed is LDHA; the disease is neoplasm.